37034751|t|Disease trajectories in elders with suspected non-Alzheimer's pathophysiology and its comparison with Alzheimer's disease pathophysiology: a longitudinal study.
37034751|a|Background According to the new 'AT(N)' system, those with a normal amyloid biomarker but with abnormal tauopathy or biomarkers of neurodegeneration or neuronal injury, have been labeled suspected non-Alzheimer's pathophysiology (SNAP). We aimed to estimate the long-term clinical and cognitive trajectories of SNAP individuals in non-demented elders and its comparison with individual in the Alzheimer's disease (AD) pathophysiology using 'AT(N)' system. Methods We included individuals with available baseline cerebrospinal fluid (CSF) Abeta (A), CSF phosphorylated tau examination (T) and 18F-fluorodeoxyglucose PET or volumetric magnetic resonance imaging (N) from the Alzheimer's Disease Neuroimaging Initiative database. Longitudinal change in clinical outcomes are assessed using linear mixed effects models. Conversion risk from cognitively normal (CN) to cognitively impairment, and conversion from mild cognitive impairment (MCI) to dementia are assessed using multivariate Cox proportional hazard models. Results Totally, 366 SNAP individuals were included (114 A-T-N-, 154 A-T + N-, 54 A-T-N + and 44 A-T + N+) of whom 178 were CN and 188 were MCI. Compared with A-T-N-, CN elders with A-T + N-, A-T-N + and A-T + N + had a faster rate of ADNI-MEM score decline. Moreover, CN older individuals with A-T + N + also had a faster rate of decline in ADNI-MEM score than those with A-T + N- individuals. MCI patients with A-T + N + had a faster rate of ADNI-MEM and ADNI-EF decline and hippocampal volume loss compared with A-T-N- and A-T + N- profiles. CN older individuals with A-T + N + had an increased risk of conversion to cognitive impairment (CDR-GS >= 0.5) compared with A-T + N- and A-T-N-. In MCI patients, A-T + N + also had an increased risk of conversion to dementia compared with A-T + N- and A-T-N-. Compared with A-T + N-, CN elders and MCI patients with A + T + N- and A + T + N + had a faster rate of ADNI-MEM score, ADNI-EF score decline, and hippocampal volume loss. CN individuals with A + T + N + had a faster rate of ADNI-EF score decline compare with A-T + N + individuals. Moreover, MCI patients with A + T + N + also had a faster rate of decline in ADNI-MEM score, ADNI-EF score and hippocampal volume loss than those with A-T + N + individuals. Conclusions The findings from clinical, imaging and biomarker studies on SNAP, and its comparison with AD pathophysiology offered an important foundation for future studies.
37034751	46	77	non-Alzheimer's pathophysiology	Disease	MESH:D000544
37034751	102	121	Alzheimer's disease	Disease	MESH:D000544
37034751	229	236	amyloid	Disease	MESH:C000718787
37034751	265	274	tauopathy	Disease	MESH:D024801
37034751	292	309	neurodegeneration	Disease	MESH:D019636
37034751	313	328	neuronal injury	Disease	MESH:D009410
37034751	358	389	non-Alzheimer's pathophysiology	Disease	MESH:D000544
37034751	391	395	SNAP	Disease	MESH:D000544
37034751	472	476	SNAP	Disease	MESH:D000544
37034751	554	573	Alzheimer's disease	Disease	MESH:D000544
37034751	575	577	AD	Disease	MESH:D000544
37034751	699	704	Abeta	Gene	351
37034751	729	732	tau	Gene	4137
37034751	753	775	18F-fluorodeoxyglucose	Chemical	MESH:D019788
37034751	834	853	Alzheimer's Disease	Disease	MESH:D000544
37034751	1025	1047	cognitively impairment	Disease	MESH:D003072
37034751	1074	1094	cognitive impairment	Disease	MESH:D003072
37034751	1096	1099	MCI	Disease	MESH:D060825
37034751	1104	1112	dementia	Disease	MESH:D003704
37034751	1198	1202	SNAP	Disease	MESH:D000544
37034751	1230	1237	114 A-T	DNAMutation	tmVar:c|SUB|A|114|T;HGVS:c.114A>T;VariantGroup:4;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1242	1249	154 A-T	DNAMutation	tmVar:c|SUB|A|154|T;HGVS:c.154A>T;VariantGroup:2;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1256	1262	54 A-T	DNAMutation	tmVar:c|SUB|A|54|T;HGVS:c.54A>T;VariantGroup:1;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1271	1277	44 A-T	DNAMutation	tmVar:c|SUB|A|44|T;HGVS:c.44A>T;VariantGroup:0;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1317	1320	MCI	Disease	MESH:D060825
37034751	1336	1339	A-T	Disease	MESH:D001260
37034751	1359	1362	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1369	1372	A-T	Disease	MESH:D001260
37034751	1381	1384	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1472	1475	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1550	1553	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1572	1575	MCI	Disease	MESH:D060825
37034751	1576	1584	patients	Species	9606
37034751	1590	1593	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1654	1677	hippocampal volume loss	Disease	MESH:D000092223
37034751	1692	1695	A-T	Disease	MESH:D001260
37034751	1703	1706	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1748	1751	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1797	1817	cognitive impairment	Disease	MESH:D003072
37034751	1848	1851	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1861	1864	A-T	Disease	MESH:D001260
37034751	1872	1875	MCI	Disease	MESH:D060825
37034751	1876	1884	patients	Species	9606
37034751	1886	1889	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1940	1948	dementia	Disease	MESH:D003704
37034751	1963	1966	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	1976	1979	A-T	Disease	MESH:D001260
37034751	1998	2001	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	2022	2025	MCI	Disease	MESH:D060825
37034751	2026	2034	patients	Species	9606
37034751	2131	2154	hippocampal volume loss	Disease	MESH:D000092223
37034751	2244	2247	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	2277	2280	MCI	Disease	MESH:D060825
37034751	2281	2289	patients	Species	9606
37034751	2378	2401	hippocampal volume loss	Disease	MESH:D000092223
37034751	2418	2421	A-T	DNAMutation	tmVar:c|SUB|A||T;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
37034751	2514	2518	SNAP	Disease	MESH:D000544
37034751	2544	2546	AD	Disease	MESH:D000544
37034751	Association	HGVS:c.114A>T;CorrespondingGene:4137	MESH:D060825
37034751	Association	CorrespondingGene:4137;CorrespondingSpecies:9606;VariantGroup:3;tmVar:c	MESH:D060825
37034751	Positive_Correlation	CorrespondingGene:4137;CorrespondingSpecies:9606;VariantGroup:3;tmVar:c	MESH:D000092223
37034751	Positive_Correlation	HGVS:c.114A>T;CorrespondingGene:4137	MESH:D000092223
37034751	Association	MESH:D060825	4137
37034751	Association	MESH:D000092223	4137

